Home > Boards > US Listed > Biotechs > Sepracor, Inc. (SEPR)

APSepracor Partners to Sell Epilepsy Drug

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
surf1944 Member Profile
 
Followed By 437
Posts 25,900
Boards Moderated 2
Alias Born 09/11/06
160x600 placeholder
surf1944   Wednesday, 01/09/08 07:25:33 PM
Re: None
Post # of 20 
AP
Sepracor Partners to Sell Epilepsy Drug
Wednesday January 2, 7:48 am ET
Sepracor Enters Partnership With Bial to Finish Developing and Sell New Epilepsy Drug

MARLBOROUGH, Mass. (AP) -- Drug developer Sepracor Inc. said Wednesday it is partnering with Portugal-based drug developer Bial to develop and sell a new epilepsy drug.
Sepracor will file a new drug application with the Food and Drug Administration, as early as late 2008 or early 2009. Bial is entitled to a $75 million payment upfront, and milestone payments up to $100 million.

The compound, called BIA 2-093, has already been tested in three late-stage studies involving more than 1,000 patients. Sepracor's drugs include Lunesta for insomnia and Xopenex for asthma.

Shares of Sepracor closed at $26.25 Monday.






surf's up......crikey



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences